RI
ANIP icon

Ridgewood Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Ridgewood Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,329
Closed -$86.7K – 223
2025
Q2 		$86.7K Hold
1,329
– – 0.04% 262
2025
Q1 		$89K Hold
1,329
– – 0.04% 254
2024
Q4 		$73.5K Hold
1,329
– – 0.04% 267
2024
Q3 		$79.3K Hold
1,329
– – 0.04% 257
2024
Q2 		$84.6K Buy
+1,329
New +$86.3K 0.04% 256
2023
Q3 		– Sell
-1,329
Closed -$71.5K – 207
2023
Q2 		$71.5K Hold
1,329
– – 0.04% 277
2023
Q1 		$52.8K Buy
+1,329
New +$56K 0.03% 328

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Ridgewood Investments's ANIP Position: Q3 2025 in Review

Ridgewood Investments sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 1,329 shares — an estimated $86.7K sold.

Ridgewood Investments first reported a position in ANIP in Q1 2023 and held it in 7 quarters. The position peaked at $89K in Q1 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • Ridgewood Investments reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Ridgewood Investments sold 1,329 ANI Pharmaceuticals shares in Q3 2025, an estimated $86.7K.
  • Ridgewood Investments first reported a position in ANI Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Ridgewood Investments's ANI Pharmaceuticals position peaked at $89K in Q1 2025.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.